Physician’s Profile

Elizabeth C. Verna, MD

Director of Clinical Research, Columbia University Transplant Initiative and the Transplant Clinical Research Center
Director of Hepatology Research, Columbia University Division of Digestive and Liver Disease
Expertise: 
Autoimmune Hepatitis
Cirrhosis
End Stage Liver Disease
Gastroenterology
Hepatitis B
Hepatitis C
Internal Medicine
Liver Cancer
Liver Disease
Liver Transplantation
Non-Alcoholic Fatty Liver Disease
Primary Sclerosing Cholangitis
Transplant Hepatology
Viral Hepatitis
About: 

Dr. Elizabeth Verna is the Frank Cardile Associate Professor of Medicine in the Center for Liver Diseaseand Transplantation and Division of Digestive and Liver Diseases at Columbia University, where shepractices as transplant hepatologist. Dr. Verna has an active clinical research program in end-stage liverdisease and liver transplantation and is the Director of Clinical Research for the Columbia UniversityTransplant Clinical Research Center.

Publications: 
Verna EC, Serper M, Chu J, Corey K, Fix OK, Hoyt K, Page KA, Loomba R, Li M, Everson GT, Fried MW, Garcia-Tsao G, Terrault N, Lok AS, Chung RT, Reddy KR. “Clinical Research in Hepatology in the COVID-19 Pandemic and Post-Pandemic Era: Challenges and the Need for Innovation” Hepatology. 2020 Epub.
Jiang L, Lang S, Duan Y, Zhang X, Gao B, Chopyk J, Schwanemann LK, Ventura-Cots M, Bataller R, Bosques-Padilla F,?Verna EC, Abraldes JG, Brown RS Jr, Vargas V, Altamirano J, Caballería J, Shawcross DL, Ho SB, Louvet A, Lucey MR, Mathurin P, Garcia-Tsao G, Kisseleva T, Brenner DA, Tu XM, Stärkel P, Pride D, Fouts DE, Schnabl B “Intestinal virome in patients with alcoholic hepatitis.” Hepatology. 2020, Epub.
Kardashian A, Ge J, McCulloch CE, Kappus MR, Dunn MA, Duarte-Rojo A, Volk ML, Rahimi RS,?Verna EC, Ganger DR, Ladner D, Dodge JL, Boyarsky B, McAdams-DeMarco M, Segev DL, Lai JC “Identifying an Optimal Liver Frailty Index Cutoff to Predict Waitlist Mortality in Liver Transplant Candidates.” Hepatology. 2020 Epub.
Phipps MM, Barraza LH, LaSota ED, Sobieszczyk ME, Pereira MR, Zheng EX, Fox AN, Zucker J,Verna EC “Acute Liver Injury in COVID-19: Prevalence and Association with Clinical Outcomes in a Large US Cohort.” Hepatology. 2020 Epub
Cullaro G,?Verna EC, Emond JC, Orandi BJ, Mohan S, Lai JC. “Early Kidney Allograft Failure After Simultaneous Liver-kidney Transplantation (SLKT): Evidence for Utilization of the Safety Net?” Transplantation. 2020?Epub
Pereira MR, Mohan S, Cohen DJ, Husain SA, Dube GK, Ratner LE, Arcasoy S, Aversa MM, Benvenuto LJ, Dadhania DM, Kapur S, Dove LM, Brown RS Jr, Rosenblatt RE, Samstein B, Uriel N, Farr MA, Satlin M, Small CB, Walsh TJ, Kodiyanplakkal RP, Miko BA, Aaron JG, Tsapepas DS, Emond JC,Verna EC.”COVID-19 in solid organ transplant recipients: Initial report from the US epicenter.” Am J Transplant. 2020 Jul;20(7):1800-1808.
Lagana SM, De Michele S, Lee MJ, Emond JC, Griesemer AD, Tulin-Silver SA,?Verna EC, Martinez M, Lefkowitch JH.”COVID-19 Associated Hepatitis Complicating Recent Living Donor Liver Transplantation.” Arch Pathol Lab Med. 2020 Epub.
Fix OK, Hameed B, Fontana RJ, Kwok RM, McGuire BM, Mulligan DC, Pratt DS, Russo MW, Schilsky ML,?Verna EC, Loomba R, Cohen DE, Bezerra JA, Reddy KR, Chung RT. “Clinical Best Practice Advice for Hepatology and Liver Transplant Providers During the COVID-19 Pandemic: AASLD Expert Panel Consensus Statement.” Hepatology. 2020 Jul;72(1):287-304.?
Verna EC, Morelli G, Terrault NA, Lok AS, Lim JK, Di Bisceglie AM, Zeuzem S, Landis CS, Kwo P, Hassan M, Manns MP, Vainorius M, Akushevich L, Nelson DR, Fried MW, Reddy KR. “DAA therapy and long-term hepatic function in advanced/decompensated cirrhosis: Real-world experience from HCV-TARGET cohort.” J Hepatol. 2020 Mar 31:S0168-8278(20)30193-8.
Lai JC, Dodge JL, Kappus MR, Dunn MA, Volk ML, Duarte-Rojo A, Ganger DR, Rahimi RS, McCulloch CE, Haugen CE, McAdams-DeMarco M, Ladner DP, Segev DL,?Verna EC; Multi-Center Functional Assessment in Liver Transplantation (FrAILT) Study.J “Changes in frailty are associated with watlist mortality in patients with cirrhosis.” J Hepatol. 2020 Mar 30:S0168-8278(20)30191-4.?
Kardashian A, Florman SS, Haydel B, Ruiz RM, Klintmalm GB, Lee DD, Taner CB, Aucejo F, Tevar AD, Humar A,?Verna EC, Halazun KJ, Chapman WC, Vachharajani N, Hoteit M, Levine MH, Nguyen MH, Melcher ML, Langnas AN, Carney CA, Mobley C, Ghobrial M, Amundsen B, Markmann JF, Sudan DL, Jones CM, Berumen J, Hemming AW, Hong JC, Kim J, Zimmerman MA, Nydam TL, Rana A, Kueht ML, Fishbein TM, Markovic D, Busuttil RW, Agopian VG. Liver Transplantation Outcomes in a U.S. Multicenter Cohort of 789 Patients with Hepatocelluular Carcinoma Presenting Beyond Milan Criteria.” Hepatology 2020, Epub.
Ghany MG, Marks KM, Morgan TR, Wyles DL, Aronsohn AI, Bhattacharya D, Broder T, Falade-Nwulia OO, Feld JJ, Gordon SC, Heller T, Jhaveri RR, Jonas MM, Kiser JJ, Linas BP, Lo Re V, Peters MG, Reddy KR, Reynolds A, Scott JD, Searson G, Spradling P, Terrault NA, Trooskin SB,?Verna EC, Wong JB, Woolley AE, Workowski KA. “Hepatitis C Guidance 2019 Update: AASLD-ISDSA Recommendations for Testing, Managing, and Treating Hepatitis C Virus Infection.” Hepatology 2019, Epub.